SCHEMBL4594596

SCHEMBL4594596

Nc1ccc2cc(C(=O)NS(=O)(=O)CC3CC(=O)N(c4ccc(N5CCCCC5=O)cc4)C3)ccc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
PRMT5 O14744 1/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 2/20 0.37
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TSHR P16473 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 3/20 0.36
GFER P55789 1/20 0.36
POLB P06746 1/20 0.36
RECQL P46063 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5640828 0.86 HSD17B10 (0.43) LMNAALDH1A1PRMT5NPC1RAB9A
SCHEMBL4593238 0.84 KLKB1 (0.42) LMNAALDH1A1KDM4EPRMT5MAPT
SCHEMBL4587719 0.80 HSD17B10 (0.44) LMNAALDH1A1PRMT5NPC1RAB9A
SCHEMBL4587128 0.79 MAPT (0.46) LMNAALDH1A1PRMT5NPC1RAB9A
SCHEMBL4602805 0.77 F10 (0.38) LMNAALDH1A1KDM4EPKMNPSR1
SCHEMBL4587483 0.76 POLB (0.47) LMNAALDH1A1PRMT5HPGDTSHR
SCHEMBL4605200 0.75 PRMT5 (0.39) LMNAALDH1A1KDM4EPKMNPSR1
SCHEMBL4594454 0.74 PRMT5 (0.43) LMNAALDH1A1PRMT5RAB9AHPGD
SCHEMBL5643671 0.74 HSD17B10 (0.42) LMNAALDH1A1PRMT5HPGDSMN1; SMN2
SCHEMBL5640731 0.74 CCR3 (0.50) LMNAALDH1A1PRMT5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667647-A4 MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-10-22 EP disclosed
EP-1667647-A2 MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2006-06-14 EP disclosed
WO-2005032468-A2 MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-04-14 WO disclosed